← Back to Search

Arm 2. Transportation, Screening, and Nurse-Visitation during Pregnancy and Infancy for Chronic Disease

N/A
Recruiting
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Women < 29 weeks pregnant with no previous live births
Timeline
Screening 3 weeks
Treatment Varies
Follow Up interview conducted approximately 30 years after delivery
Awards & highlights

Study Summary

This trial looks at how prenatal care and early child home visits can affect long-term health risks for a mom and her child.

Who is the study for?
This trial is for first-time pregnant women under 29 weeks with no severe chronic illnesses. It's aimed at those who have participated in a nurse home visiting program and face socioeconomic challenges, such as being unmarried, having less than a high school education, or being unemployed.Check my eligibility
What is being tested?
The study examines the long-term effects of prenatal and early childhood home visits by nurses on reducing risks for chronic diseases in mothers and their children. Participants receive transportation support and developmental screenings.See study design
What are the potential side effects?
Since this trial involves non-medical interventions like nurse visitation, transportation assistance, and developmental screening rather than drugs or medical procedures, it does not have typical side effects associated with clinical trials.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am pregnant, less than 29 weeks along, and have never had a live birth.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~interview conducted approximately 30 years after delivery
This trial's timeline: 3 weeks for screening, Varies for treatment, and interview conducted approximately 30 years after delivery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
% body fat in arms, legs
Augmentation index
Carotid to femoral pulse wave velocity (cf-PWV)
+22 more
Secondary outcome measures
Anxiety
Arrests
Arrests and Incarceration
+42 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Arm 2. Transportation, Screening, and Nurse-Visitation during Pregnancy and InfancyExperimental Treatment1 Intervention
Free transportation for scheduled prenatal care; intensive nurse home-visitation services during pregnancy and through the child's second birthday; and developmental screening and referral services for the child at the 6th, 12th, and 24th months of the child's life.
Group II: Arm 1. Transportation and ScreeningActive Control1 Intervention
Free transportation for scheduled prenatal care, developmental screening and referral services for the child at the 6th, 12th, and 24th months of the child's life.

Find a Location

Who is running the clinical trial?

Medpace, Inc.Industry Sponsor
94 Previous Clinical Trials
28,873 Total Patients Enrolled
University of Colorado, DenverLead Sponsor
1,738 Previous Clinical Trials
2,148,784 Total Patients Enrolled
6 Trials studying Chronic Disease
965 Patients Enrolled for Chronic Disease
University of RochesterOTHER
840 Previous Clinical Trials
533,508 Total Patients Enrolled
1 Trials studying Chronic Disease
60 Patients Enrolled for Chronic Disease

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available vacancies in this trial for participants?

"According to clinicaltrials.gov, this medical experiment is actively recruiting participants since its inception on the 20th of May 2020 and latest update on 28th November 2023."

Answered by AI

How many participants are presently enrolled in the trial?

"Affirmative. Clinicaltrials.gov has the most up-to-date information, and it indicates that this research is currently open to participants; first posted on May 20th 2020 and last updated November 28th 2023. 742 people need to be enrolled at 1 site for this study."

Answered by AI

What are the primary aims of this experiment?

"Medpace, Inc., the trial's sponsor has declared that Weight is to be evaluated as the primary outcome over a span of 30 years. Other metrics such as Disability (injury), Birthweight and Gestational age are also being collected for secondary analysis utilizing both interview data and administrative records like Social Security disability payment information or birth certificates."

Answered by AI
~151 spots leftby Apr 2025